NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Oramed Pharmaceuticals Inc. Share Price Chart

O H L

Oramed Pharmaceuticals Inc. Performance Overview

Days Range
$4.64Low
$4.69High

Markets Today

Previous Close$4.67
Open$4.64
Volume50,017
Day's Range$4.64 - $4.69
52W Range$1.95 - $5.47
Market Cap$192.18 M

Historical Performance

1M Returns-2.30
3M Returns+20.36
6M Returns+30.81
1Y Returns+91.39
5Y Returns-77.22
10Y Returns-37.06

Oramed Pharmaceuticals Inc. Fundamentals

Market Cap$192.18 M
Dividend yield0.00
PE Ratio1.12
PEG RatioN/A
Revenue$2.00 M
ROE TTM0.37
EPS TTM$4.13
Quarterly Earnings Growth YOYN/A
PB Ratio0.60
EBITDA$-14.97 M
Profit Margin3162.10
Market Cap$192.18 M
Dividend yield0.00
PE Ratio1.12
PEG RatioN/A
Revenue$2.00 M
ROE TTM0.37
EPS TTM$4.13
Quarterly Earnings Growth YOYN/A
PB Ratio0.60
EBITDA$-14.97 M
Profit Margin3162.10

Oramed Pharmaceuticals Inc. Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$2.00 M$0$0$0$0$0
Gross Profit +$13.00 K$0$0$0$0$0
Operating Income -$4.50 M-$2.49 M-$2.43 M-$5.67 M-$3.66 M-$2.77 M
EBITDA -$4.47 M-$2.46 M-$2.40 M-$5.64 M-$3.63 M-$2.73 M
Interest Expense $0$0$0$0$0$0
Depreciation $30.00 K$30.00 K$31.00 K$30.00 K$30.00 K$31.00 K
Income Before Tax -$7.06 M$13.13 M$59.45 M$9.80 M$49.44 M$101.59 M
Income Tax Expense $584.00 K-$126.00 K$11.06 M-$212.00 K$11.13 M$23.43 M
Net Income +-$7.64 M$13.26 M$48.39 M$10.01 M$38.31 M$78.16 M
Net Profit Margin -382.1%-----

Oramed Pharmaceuticals Inc. Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $491.00 K$491.00 K$490.00 K$472.00 K$491.00 K$495.00 K
Reserve & Surplus -$184.26 M-$170.97 M-$122.58 M-$123.44 M-$85.12 M-$6.96 M
Non-Current Liabilities $2.15 M$4.41 M$12.04 M$12.03 M$20.01 M$41.44 M
Current Liabilities $5.49 M$3.69 M$6.12 M$19.09 M$10.56 M$10.73 M
Total Liabilities $7.64 M$8.10 M$18.16 M$31.12 M$30.57 M$52.17 M
Fixed Assets $671.00 K$645.00 K$614.00 K$586.00 K$561.00 K$532.00 K
Current Assets $131.48 M$99.03 M$136.12 M$133.27 M$68.15 M$53.41 M
Total Assets $147.54 M$161.68 M$220.49 M$230.86 M$268.85 M$369.64 M

Oramed Pharmaceuticals Inc. Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$7.64 M$13.26 M$48.39 M$10.01 M$38.31 M$78.16 M
Operating Cash Flow -$3.52 M-$3.54 M-$1.63 M-$466.00 K-$2.92 M-$200.00 K
Investing Cash Flow $23.62 M-$54.85 M$38.36 M-$1.68 M-$19.49 M$4.31 M
Financing Cash Flow $0-$371.00 K-$361.00 K-$4.01 M-$10.36 M-$1.95 M
Change in Cash $20.10 M-$58.72 M$36.38 M-$6.23 M-$32.74 M$2.04 M

Oramed Pharmaceuticals Inc. Return Calculator

The Oramed Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$2,259
Invested Amount$10,000
Est. Returns$-7,741
Invest in USA Stock Today

About Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.

FAQs

Oramed Pharmaceuticals Inc. (ORMP) share price as of September 18, 2026 is $4.63. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Oramed Pharmaceuticals Inc. (ORMP) Share by opening an international trading account with Angel One.
Purchasing Oramed Pharmaceuticals Inc. (ORMP) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Oramed Pharmaceuticals Inc. (ORMP) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Oramed Pharmaceuticals Inc. (ORMP) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Oramed Pharmaceuticals Inc. on September 18, 2026, is $192.18 M.
Oramed Pharmaceuticals Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Oramed Pharmaceuticals Inc. (ORMP) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91